Longevity factor klotho enhances cognition in aged nonhuman primates.
Nat Aging
; 3(8): 931-937, 2023 08.
Article
en En
| MEDLINE
| ID: mdl-37400721
Cognitive dysfunction in aging is a major biomedical challenge. Whether treatment with klotho, a longevity factor, could enhance cognition in human-relevant models such as in nonhuman primates is unknown and represents a major knowledge gap in the path to therapeutics. We validated the rhesus form of the klotho protein in mice showing it increased synaptic plasticity and cognition. We then found that a single administration of low-dose, but not high-dose, klotho enhanced memory in aged nonhuman primates. Systemic low-dose klotho treatment may prove therapeutic in aging humans.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Glucuronidasa
/
Longevidad
Tipo de estudio:
Prognostic_studies
Límite:
Aged
/
Animals
/
Humans
Idioma:
En
Revista:
Nat Aging
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos